Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $22.62M | 41,889,142 | 12.20% | 14.47% | Net Buying | |||
| KALA | KALA BIO INC | $9.94M | 6,452,398 | 6.83% | 93.17% | Net Selling | Net Selling | ||
| ACXP | ACURX PHARMACEUTICALS INC | $7.23M | 1,584,775 | 50.36% | 49.64% | Net Buying | |||
| ATYR | ATYR PHARMA INC | $63.19M | 89,004,436 | 74.54% | 17.28% | Net Buying | |||
| MRSN | MERSANA THERAPEUTICS INC | $39.93M | 4,990,692 | 30.77% | 69.23% | Net Selling | Net Selling | ||
| FEMY | FEMASYS INC | $11.30M | 27,239,885 | 18.82% | 8.69% | Net Buying | |||
| GOVX | GEOVAX LABS INC | $14.07M | 25,359,593 | 0.21% | 99.79% | Net Buying | Net Buying | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $81.60M | 17,661,698 | 29.13% | 25.91% | ||||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $29.06M | 57,542,105 | 11.22% | 38.43% | Net Selling | |||
| FGEN | FIBROGEN INC | $48.24M | 4,043,899 | 8.14% | 91.86% | Net Buying | Net Selling | ||
| NRXP | NRX PHARMACEUTICALS INC | $65.62M | 19,705,077 | 5.67% | 94.33% | Net Buying | |||
| SGMO | SANGAMO THERAPEUTICS INC | $211.20M | 301,709,485 | 16.98% | 10.66% | Net Selling | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $67.70M | 99,264,526 | 0.38% | 23.66% | Net Buying | Net Buying | ||
| GRI | GRI BIO INC | $4.96M | 2,515,305 | 0.71% | 99.29% | ||||
| BTAI | BIOXCEL THERAPEUTICS INC | $38.43M | 14,556,743 | 0.31% | 99.69% | Net Selling | |||
| BOLT | BOLT BIOTHERAPEUTICS INC | $9.52M | 1,919,441 | 4.26% | 95.74% | Net Buying | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.81M | 23,858,301 | 10.74% | 60.23% | ||||
| MDCX | MEDICUS PHARMA LTD | $44.72M | 17,816,266 | 11.79% | 55.54% | Net Buying | Net Buying | ||
| LSTA | LISATA THERAPEUTICS INC | $21.93M | 8,598,204 | 0.89% | 99.11% | Net Selling | |||
| MTVA | METAVIA INC | $23.76M | 24,197,809 | 0.81% | 99.19% | Net Buying | |||
| KAPA | KAIROS PHARMA LTD | $23.86M | 20,743,765 | 1.05% | 32.68% | Net Buying | |||
| CING | CINGULATE INC | $21.97M | 5,412,523 | 3.75% | 96.25% | ||||
| CRDL | CARDIOL THERAPEUTICS INC | $86.81M | 82,674,725 | 7.82% | 0.00% | ||||
| MYO | MYOMO INC | $34.66M | 37,801,070 | 50.77% | 11.23% | Net Selling | Net Buying | ||
| CERO | CERO THERAPEUTICS HOLDINGS INC | $6.50M | 1,205,402 | 0.38% | 99.62% | Net Selling | |||
| INTS | INTENSITY THERAPEUTICS INC | $12.71M | 47,057,727 | 4.20% | 4.44% | Net Buying | |||
| JSPR | JASPER THERAPEUTICS INC | $39.33M | 16,253,332 | 20.42% | 79.58% | Net Buying | Net Buying | ||
| SLN | SILENCE THERAPEUTICS PLC | $245.37M | 141,701,848 | 13.95% | 0.09% | ||||
| IPSC | CENTURY THERAPEUTICS INC | $43.02M | 86,389,098 | 26.19% | 48.12% | Net Selling | Net Selling | ||
| MBRX | MOLECULIN BIOTECH INC | $15.14M | 30,286,168 | 1.43% | 20.90% | Net Buying | |||
| NOTE | FISCALNOTE HOLDINGS INC | $71.32M | 14,349,995 | 30.70% | 69.30% | Net Selling | Net Selling | ||
| PMN | PROMIS NEUROSCIENCES INC | $24.25M | 51,806,497 | 16.36% | 49.79% | Net Buying | |||
| PASG | PASSAGE BIO INC | $25.59M | 3,178,710 | 48.56% | 51.44% | Net Selling | Net Buying | ||
| IMUX | IMMUNIC INC | $92.27M | 95,817,536 | 52.37% | 16.57% | Net Buying | |||
| TIL | INSTIL BIO INC | $118.48M | 6,750,716 | 5.76% | 94.24% | Net Buying | Net Buying | ||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $11.86M | 1,261,290 | 0.39% | 99.61% | Net Selling | |||
| ACET | ADICET BIO INC | $68.48M | 82,709,625 | 62.39% | 19.44% | Net Selling | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $33.19M | 68,003,613 | 21.00% | 15.70% | ||||
| EKSO | EKSO BIONICS HOLDINGS INC | $13.89M | 2,611,788 | 0.26% | 99.74% | ||||
| ATOS | ATOSSA THERAPEUTICS INC | $118.84M | 129,171,424 | 16.53% | 11.04% | Net Buying | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $286.23M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| ANVS | ANNOVIS BIO INC | $43.45M | 19,486,231 | 9.30% | 15.63% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.